Impaired Cell-Cleanup Is a Predictor of Postpartum Depression, Cornell Study Finds

Autophagy, the process by which the body recycles damaged cell parts into fully functioning cell parts, may be dampened in women with postpartum depression, according to a recent Cornell Weill study done in collaboration with John Hopkins University School of Medicine and the University of Virginia Health.  

Weill Scientists Reach New Heights With Multiple Sclerosis Drug Treatment

On Feb. 8, a new study on the multiple sclerosis drug siponimod conducted by researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center was published in Nature Communications. The study analyzed the drug’s shape and interactions in the body, allowing researchers to understand how to lessen the drug’s side effects, such as heart and liver problems, during treatment for MS patients. 

Weill Scientists Make Strides in Understanding Gut Microbiota

Cornell Weill scientists have recently developed a pipeline which creates direct access to singular genes of the organisms within the gut microbiome, advancing the foundational understanding of diseases within the human body as these singular genes can be manipulated and their effects observed. 

Weill Faculty Member Dr. Vanessa Rouzier Discusses Leading Haiti Cholera Response Efforts

On Jan. 10, 2010, a 7.0 magnitude earthquake struck the heart of Haiti, displacing millions of people, destroying much of the country’s infrastructure and ultimately creating nearly inhabitable conditions — a common recipe for a disease outbreak to take hold. It was not unexpected when Haiti then experienced the worst cholera outbreak in modern history.

As Cuomo Issues New Executive Order, Weill Cornell Medicine Ramps Up COVID-19 Testing

As many people yearn to return to some form of normalcy, states are beginning to consider what the reopening of nonessential businesses should look like. In his daily press briefing Gov. Andrew Cuomo (D-N.Y.) said a crucial first step for reopening is widespread COVID-19 testing — which New York State currently lacks.

On that same day, Dr. Augustine M.K. Choi, Weill Cornell Dean, announced a new initiative to begin antibody testing employees of Weill Cornell.